Brain study reveals cause of apathy in schizophrenia

Bris­tol My­ers Squibb like­ly won’t be on the hunt for big M&A tar­gets in 2024 af­ter pulling off a $14 bil­lion deal for Karuna Ther­a­peu­tics

Gene ther­a­py start­up Cap­si­da Bio­ther­a­peu­tics said it is lay­ing off em­ploy­ees, months af­ter un­veil­ing two Big Phar­ma part­ner­ships that brought in $125 mil­lion. Cap­si­da CEO Pe­ter Anas­ta­siou de­clined

More drugs than ever will be sub­ject to Medicare in­fla­tion re­bates un­der the In­fla­tion Re­duc­tion Act next quar­ter. On Wednes­day, the De­part­ment of Health and